NeuroKaire Israeli Company
NeuroKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The NeuroKaire test predicts the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Health Tech & Life Sciences
Health Care
Personal Health
Psychology
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
{
$el.querySelectorAll('a').forEach(link => {
link.target = '_blank';
link.rel = 'noopener noreferrer';
});
})"
class="ai-alternatives-content prose prose-sm dark:prose-invert prose-headings:text-gray-900 dark:prose-headings:text-gray-100 prose-p:text-gray-700 dark:prose-p:text-gray-300 prose-strong:text-gray-900 dark:prose-strong:text-gray-100 max-w-none [&>h2]:mb-4 [&>h2]:mt-8 [&>h3]:mb-3 [&>h3]:mt-6 [&>p]:mb-4 [&>ul>li]:my-2 [&>ul]:space-y-3"
>
Suggest an Alternative
Founders
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/neurokaire
[2]
crunchbase.com
- https://www.crunchbase.com/organization/genetika
External links are provided for reference and verification purposes.